...
首页> 外文期刊>Endoscopy International Open >A self-assembling matrix-forming gel can be easily and safely applied to prevent delayed bleeding after endoscopic resections
【24h】

A self-assembling matrix-forming gel can be easily and safely applied to prevent delayed bleeding after endoscopic resections

机译:自组装基质形成凝胶可轻松安全地使用,以防止在内窥镜切除术后延迟出血

获取原文
           

摘要

Background: Endoscopic resections have low morbidity and mortality. Delayed bleeding has been reported in approximately 1?–?15?% of cases, increasing with antiplatelet/anticoagulant therapy or portal hypertension. A self-assembling peptide (SAP) forming a gel could protect the mucosal defect during early healing. This retrospective trial aimed to assess the safety and efficacy of SAP in preventing delayed bleeding after endoscopic resections. Methods: Consecutive patients with endoscopic resections were enrolled in two tertiary referral centers. Patients with a high risk of bleeding (antiplatelet agents, anticoagulation drugs with heparin bridge therapy, and cirrhosis with portal hypertension) were also included. The SAP gel was applied immediately after resection to cover the whole ulcer bed. Results: In total, 56 patients were included with 65 lesions (esophagus [n?=?8], stomach [n?=?22], duodenum [n?=?10], ampullary [n?=?3], colon [n?=?7], and rectum [n?=?15]) in two centers. Among those 65 lesions, 29 were resected in high risk situations (9 uninterrupted aspirin therapy, 6 heparin bridge therapies, 5 cirrhosis and portal hypertension, 1 both cirrhosis and heparin bridge, 3 both cirrhosis and uninterrupted aspirin, 3 large duodenal lesions >?2?cm, and 2 early introduction of clopidogrel at day 1). The resection technique was endoscopic submucosal dissection (ESD) in 40 cases, en bloc endoscopic mucosal resection (EMR) in 16, piecemeal EMR in 6, and ampullectomy in 3.?The mean lesion size was 37.9?mm (SD: 2.2?mm) with a mean area of 6.3?cm2 (SD: 3.5?cm2). No difficulty was noted during application. Four delayed overt bleedings occurred (6.2?%) (3 hematochezia, 1 hematemesis) requiring endoscopic hemostasis. The mean hemoglobin drop off was 0.6?g/dL (–?0.6 to 3.1?g/dL). No adverse events occurred. Conclusion: The use of this novel extracellular matrix scaffold may help to reduce post-endoscopic resection bleedings including in high risk situations. Its use is easy and safe but further comparative studies are warranted to completely evaluate its effectiveness.
机译:背景:内窥镜切除术的发病率和死亡率均较低。据报道,约有1%至15%的患者出现延迟出血,随着抗血小板/抗凝治疗或门脉高压的发生而增加。形成凝胶的自组装肽(SAP)可以在早期愈合过程中保护粘膜缺损。这项回顾性试验旨在评估SAP预防内镜切除术后延迟出血的安全性和有效性。方法:将连续内镜切除术的患者纳入两个三级转诊中心。还包括出血风险高的患者(抗血小板药,肝素桥治疗抗凝药和门静脉高压性肝硬化)。切除后立即使用SAP凝胶覆盖整个溃疡床。结果:总共56例患者包括65个病变(食管[n = 8],胃[n = 22],十二指肠[n = 10],壶腹[n = 3],结肠)。 [n?=?7]和直肠[n?=?15])位于两个中心。在这65个病变中,有29例在高危情况下被切除(9例不间断的阿司匹林治疗,6例肝素桥治疗,5例肝硬化和门脉高压,1例肝硬化和肝素桥,3例肝硬化和不间断阿司匹林,3例大于2的十二指肠大病变?cm,并在第1天2早期引入氯吡格雷。切除技术为内镜下黏膜下剥离术(ESD)40例,整体内镜下黏膜切除术(EMR)16例,小肠EMR术6例,壶腹切除术3例。平均病变大小为37.9?mm(SD:2.2?mm)。 ),平均面积为6.3?cm2(标准差:3.5?cm2)。在施用过程中没有发现任何困难。发生四次延迟性明显出血(6.2%)(3次便血,1次呕血),需要内镜止血。平均血红蛋白下降为0.6?g / dL(-0.6至3.1?g / dL)。没有发生不良事件。结论:这种新型细胞外基质支架的使用可能有助于减少内镜切除后的出血,包括在高危情况下。它的使用既简单又安全,但是必须进行进一步的比较研究才能完全评估其有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号